Crinetics Pharmaceuticals Inc. (CRNX) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-11-14
1:22 pm
Purchase
2024-09-3013GCRINETICS PHARMACEUTICALS INC
CRNX
T. Rowe Price Associates, Inc.4,944,757
6.200%
4,944,757increase
(New Position)
Filing
History
2024-11-12
2:26 pm
Unchanged
2024-09-3013GCRINETICS PHARMACEUTICALS INC
CRNX
VANGUARD GROUP INC6,287,655
7.850%
0
(Unchanged)
Filing
History
2024-11-08
10:52 am
Purchase
2024-09-3013GCRINETICS PHARMACEUTICALS INC
CRNX
Wellington Management Group LLP4,459,691
5.570%
1,214,586increase
(+37.43%)
Filing
History
2024-11-04
11:20 am
Purchase
2024-09-3013GCRINETICS PHARMACEUTICALS INC
CRNX
VANGUARD GROUP INC6,287,655
7.850%
2,785,203increase
(+79.52%)
Filing
History
2024-10-17
12:47 pm
Sale
2024-09-3013GCRINETICS PHARMACEUTICALS INC
CRNX
STATE STREET CORP
STT
2,838,484
3.600%
-725,252decrease
(-20.35%)
Filing
History
2024-03-11
3:34 pm
Purchase
2024-02-2813GCRINETICS PHARMACEUTICALS INC
CRNX
EcoR1 Capital, LLC4,155,375
5.300%
4,155,375increase
(New Position)
Filing
History
2024-03-01
8:05 pm
Sale
2023-05-2413DCRINETICS PHARMACEUTICALS INC
CRNX
Perceptive Advisors LLC1,488,703
1.900%
-3,844,829decrease
(-72.09%)
Filing
History
2024-02-14
6:36 pm
Sale
2023-12-3113GCRINETICS PHARMACEUTICALS INC
CRNX
ORBIMED ADVISORS LLC1,667,360
2.500%
-1,529,516decrease
(-47.84%)
Filing
History
2024-02-14
4:14 pm
Sale
2023-12-3113GCRINETICS PHARMACEUTICALS INC
CRNX
Point72 Asset Management, L.P.3,416,900
5.100%
-311,052decrease
(-8.34%)
Filing
History
2024-02-14
4:06 pm
Sale
2023-12-3113GCRINETICS PHARMACEUTICALS INC
CRNX
BRAIDWELL LP0
0.000%
-3,469,674decrease
(Position Closed)
Filing
History
2024-02-14
10:11 am
Sale
2023-12-3113GCRINETICS PHARMACEUTICALS INC
CRNX
BIOTECHNOLOGY VALUE FUND L P0
0.000%
-2,736,613decrease
(Position Closed)
Filing
History
2024-02-14
07:54 am
Sale
2023-12-3113GCRINETICS PHARMACEUTICALS INC
CRNX
DRIEHAUS CAPITAL MANAGEMENT LLC5,039,477
7.540%
-585,267decrease
(-10.41%)
Filing
History
2024-02-13
5:02 pm
Purchase
2023-12-2913GCRINETICS PHARMACEUTICALS INC
CRNX
VANGUARD GROUP INC3,502,452
5.240%
3,502,452increase
(New Position)
Filing
History
2024-02-09
08:50 am
Purchase
2024-02-0813GCRINETICS PHARMACEUTICALS INC
CRNX
FMR LLC4,043,865
6.053%
2,160,747increase
(+114.74%)
Filing
History
2024-02-08
10:11 am
Purchase
2023-12-2913GCRINETICS PHARMACEUTICALS INC
CRNX
Wellington Management Group LLP3,245,105
4.860%
440,620increase
(+15.71%)
Filing
History
2024-01-25
4:59 pm
Purchase
2023-12-3113GCRINETICS PHARMACEUTICALS INC
CRNX
BlackRock, Inc.
BLK
5,345,114
8.000%
1,427,625increase
(+36.44%)
Filing
History
2024-01-24
10:28 am
Purchase
2023-12-3113GCRINETICS PHARMACEUTICALS INC
CRNX
STATE STREET CORP
STT
3,563,736
5.340%
3,563,736increase
(New Position)
Filing
History
2023-09-18
4:24 pm
Purchase
2023-09-1513GCRINETICS PHARMACEUTICALS INC
CRNX
Point72 Asset Management, L.P.3,727,952
5.600%
3,727,952increase
(New Position)
Filing
History
2023-02-14
4:12 pm
Unchanged
2022-12-3113GCRINETICS PHARMACEUTICALS INC
CRNX
ORBIMED ADVISORS LLC3,196,876
5.900%
0
(Unchanged)
Filing
History
2023-02-14
4:06 pm
Purchase
2022-12-3113GCRINETICS PHARMACEUTICALS INC
CRNX
BRAIDWELL LP3,469,674
6.450%
3,469,674increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2, Next